Inactive Instrument

Highlights SofWave Medical Ltd. TEL AVIV STOCK EXCHANGE

Equities

SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Sofwave Medical Receives 510(K) Marketing Clearance for Pure Impact Strength and Muscle Toning Body Module Utilizing Plyopulse EMS Technology	Jan. 03	CI
SofWave Medical Ltd. Receives FDA Clearance of Superb?? Technology for Improvement of the Appearance of Skin Laxity on the Upper Arm	Dec. 26	CI
SofWave Medical Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Sofwave Medical Announces FDA Clearance of SUPERB? Technology For Treatment of Acne Scars	23-08-30	CI
SofWave Medical Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Sofwave Medical Ltd. Gains Additional U.S. Patent Protection for the Company's Proprietary SUPERBâ„¢ Technology	23-07-05	CI
SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-08	CI

No results for this search